This Article Figures Only Full Text Full Text (PDF) View Related Story on Cardiosmart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Daniels, L. B. Articles by Barrett-Connor, E. Search for Related Content PubMed PubMed Citation Articles by Daniels, L. B. Articles by Barrett-Connor, E. Related Collections Related Article

CLINICAL RESEARCH: BIOMARKERS

Minimally Elevated Cardiac Troponin T and Elevated N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality in Older Adults

Results From the Rancho Bernardo Study

Lori B. Daniels, MD, MAS^_*,_*, Gail A. Laughlin, PhD, Paul Clopton, MS^_*,, Alan S. Maisel, MD, FACC^_*, and Elizabeth Barrett-Connor, MD

^_* Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, California
Department of Family and Preventive Medicine, University of California at San Diego, San Diego, California
Veteran's Affairs San Diego Healthcare System, La Jolla, California.

Manuscript received January 18, 2008; revised manuscript received April 23, 2008, accepted April 27, 2008.

^_* Reprint requests and correspondence: Dr. Lori B. Daniels, Mail Code 0986, 9350 Campus Point Drive, Suite 1D, La Jolla, California 92037-1300. (Email: lbdaniels{at}ucsd.edu).

Objectives: This study investigated the prognostic value of detectable cardiac troponin T (TnT) and elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in a population of community-dwelling older adults.

Background: Minimally elevated levels of TnT, a marker of cardiomyocyte injury, have been found in small subsets of the general population, with uncertain implications. A marker of ventricular stretch, NT-proBNP has clinical utility in many venues, but its long-term prognostic value in apparently healthy older adults and in conjunction with TnT is unknown.

Methods: Participants were 957 older adults from the Rancho Bernardo Study with plasma NT-proBNP and TnT measured at baseline (1997 to 1999) and followed up for mortality through July 2006.

Results: Participants with detectable TnT (0.01 ng/ml, n = 39) had an increased risk of all-cause and cardiovascular death (adjusted hazard ratio [HR] by Cox proportional hazards analysis: 2.06; 95% confidence interval [CI]: 1.29 to 3.28, p = 0.003 for all-cause mortality; HR: 2.06, 95% CI: 1.03 to 4.12, p = 0.040 for cardiovascular mortality); elevated NT-proBNP also predicted an increased risk of all-cause and cardiovascular mortality (adjusted HR per unit-log increase in NT-proBNP: 1.85, 95% CI: 1.36 to 2.52, p < 0.001 for all-cause mortality; HR: 2.51, 95% CI: 1.55 to 4.08, p < 0.001 for cardiovascular mortality). Those with both elevated NT-proBNP and detectable TnT had poorer survival (HR for high NT-proBNP and detectable TnT vs. low NT-proBNP and any TnT: 3.20, 95% CI: 1.91 to 5.38, p < 0.001). Exclusion of the 152 participants with heart disease at baseline did not materially change the TnT mortality or NT-proBNP mortality associations.

Conclusions: Apparently healthy adults with detectable TnT or elevated NT-proBNP levels are at increased risk of death. Those with both TnT and NT-proBNP elevations are at even higher risk, and the increased risk persists for years.

Key Words: aging • cardiovascular diseases • epidemiology • natriuretic peptides • prognosis • risk factors • survival

Abbreviations and Acronyms   AUC = area under the receiver-operator characteristic curve   BMI = body mass index   BUN = blood urea nitrogen   CHD = coronary heart disease   CVD = cardiovascular disease   HR = hazard ratio   NT-proBNP = N-terminal pro-B-type natriuretic peptide   ROC = receiver-operator characteristic   TnT = troponin T

Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A31-A32. [Full Text] [PDF]

This article has been cited by other articles:

				J. Rubin, K. Matsushita, C. M. Ballantyne, R. Hoogeveen, J. Coresh, and E. Selvin Chronic Hyperglycemia and Subclinical Myocardial Injury J. Am. Coll. Cardiol., January 31, 2012; 59(5): 484 - 489. [Abstract] [Full Text] [PDF]

				A. T. Turer, T. A. Addo, J. L. Martin, M. S. Sabatine, G. D. Lewis, R. E. Gerszten, E. C. Keeley, J. E. Cigarroa, R. A. Lange, L. D. Hillis, et al. Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay: Insights From a Coronary Sinus Sampling Study J. Am. Coll. Cardiol., June 14, 2011; 57(24): 2398 - 2405. [Abstract] [Full Text] [PDF]

				S. J. Aldous, C. M. Florkowski, I. G. Crozier, P. George, R. Mackay, and M. Than High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain Ann Clin Biochem, May 1, 2011; 48(3): 249 - 255. [Abstract] [Full Text] [PDF]

				J. T. Saunders, V. Nambi, J. A. de Lemos, L. E. Chambless, S. S. Virani, E. Boerwinkle, R. C. Hoogeveen, X. Liu, B. C. Astor, T. H. Mosley, et al. Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study Circulation, April 5, 2011; 123(13): 1367 - 1376. [Abstract] [Full Text] [PDF]

				E. J. van den Bos, A. A. Constantinescu, R. T. van Domburg, S. Akin, L. J. Jordaens, and M. J. M. Kofflard Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation Eur. Heart J., March 1, 2011; 32(5): 611 - 617. [Abstract] [Full Text] [PDF]

				Y. Xue, P. Clopton, W. F. Peacock, and A. S. Maisel Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure Eur J Heart Fail, January 1, 2011; 13(1): 37 - 42. [Abstract] [Full Text] [PDF]

				Writing Committee Members, P. Greenland, J. S. Alpert, G. A. Beller, E. J. Benjamin, M. J. Budoff, Z. A. Fayad, E. Foster, M. A. Hlatky, J. M. Hodgson, et al. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation, December 21, 2010; 122(25): e584 - e636. [Full Text] [PDF]

				P. Greenland, J. S. Alpert, G. A. Beller, E. J. Benjamin, M. J. Budoff, Z. A. Fayad, E. Foster, M. A. Hlatky, J. M. Hodgson, F. G. Kushner, et al. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance J. Am. Coll. Cardiol., December 14, 2010; 56(25): e50 - e103. [Full Text] [PDF]

				L. B. Daniels and A. S. Maisel Multiple marker approach to risk stratification in patients with stable coronary artery disease: to have or have not Eur. Heart J., December 2, 2010; 31(24): 2980 - 2983. [Full Text] [PDF]

				A. S. Jaffe Chapter 33 The use of biomarkers for acute cardiovascular disease The ESC Textbook of Acute and Intensive Cardiac Care, December 1, 2010; 1(1): med-9780199584314-chapter - med-9780199584314-chapter. [Abstract] [Full Text] [PDF]

				U. Alehagen, U. Dahlstrom, J. F. Rehfeld, and J. P. Goetze Prognostic Assessment of Elderly Patients with Symptoms of Heart Failure by Combining High-Sensitivity Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide Measurements Clin. Chem., November 1, 2010; 56(11): 1718 - 1724. [Abstract] [Full Text] [PDF]

				J. D. Muehlschlegel, T. E. Perry, K.-Y. Liu, A. A. Fox, C. D. Collard, S. K. Shernan, and S. C. Body Heart-Type Fatty Acid Binding Protein Is an Independent Predictor of Death and Ventricular Dysfunction After Coronary Artery Bypass Graft Surgery Anesth. Analg., November 1, 2010; 111(5): 1101 - 1109. [Abstract] [Full Text] [PDF]

				K. Thygesen, J. Mair, H. Katus, M. Plebani, P. Venge, P. Collinson, B. Lindahl, E. Giannitsis, Y. Hasin, M. Galvani, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care Eur. Heart J., September 2, 2010; 31(18): 2197 - 2204. [Abstract] [Full Text] [PDF]

				J. A. de Lemos and A. Rohatgi Separating the Contenders From the Pretenders: Competitive High-Throughput Biomarker Screening in Large Population-Based Studies Circulation, June 8, 2010; 121(22): 2381 - 2383. [Full Text] [PDF]

				W. H. W. Tang, Y. Wu, S. J. Nicholls, D. M. Brennan, M. Pepoy, S. Mann, A. Pratt, F. Van Lente, and S. L. Hazen Subclinical Myocardial Necrosis and Cardiovascular Risk in Stable Patients Undergoing Elective Cardiac Evaluation Arterioscler Thromb Vasc Biol, March 1, 2010; 30(3): 634 - 640. [Abstract] [Full Text] [PDF]

				J. H.W. Rutten, F. U.S. Mattace-Raso, E. W. Steyerberg, J. Lindemans, A. Hofman, R. G. Wieberdink, M. M.B. Breteler, J. C.M. Witteman, and A. H. van den Meiracker Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Cardiovascular and Cerebrovascular Risk Prediction in the Population: The Rotterdam Study Hypertension, March 1, 2010; 55(3): 785 - 791. [Abstract] [Full Text] [PDF]

				E. Giannitsis, K. Kurz, K. Hallermayer, J. Jarausch, A. S. Jaffe, and H. A. Katus Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay Clin. Chem., February 1, 2010; 56(2): 254 - 261. [Abstract] [Full Text] [PDF]

				E. Di Angelantonio, R. Chowdhury, N. Sarwar, K. K. Ray, R. Gobin, D. Saleheen, A. Thompson, V. Gudnason, N. Sattar, and J. Danesh B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies Circulation, December 1, 2009; 120(22): 2177 - 2187. [Abstract] [Full Text] [PDF]

				M. Bonham and S. Miller Clinical Comparison of 99th Percentile and 10% Coefficient of Variation Cutoff Values for Four Commercially Available Troponin I Assays Lab Med, August 1, 2009; 40(8): 470 - 473. [Abstract] [Full Text] [PDF]

				J. D. Muehlschlegel, T. E. Perry, K.-Y. Liu, L. Nascimben, A. A. Fox, C. D. Collard, E. G. Avery, S. F. Aranki, M. N. D'Ambra, S. K. Shernan, et al. Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting Eur. Heart J., July 1, 2009; 30(13): 1574 - 1583. [Abstract] [Full Text] [PDF]

				Y. R.B.M. van Gestel, D. D. Sin, and D. Poldermans Elevated N-Terminal Pro-B-Type Natriuretic Peptide Levels: The Effect of Chronic Obstructive Pulmonary Disease J. Am. Coll. Cardiol., February 3, 2009; 53(5): 458 - 458. [Full Text] [PDF]

				L. B. Daniels, G. A. Laughlin, P. Clopton, A. S. Maisel, and E. Barrett-Connor Reply J. Am. Coll. Cardiol., February 3, 2009; 53(5): 458 - 459. [Full Text] [PDF]

				H.A. Katus, E. Giannitsis, A.S. Jaffe, and K. Thygesen Higher sensitivity troponin assays: Quo vadis? Eur. Heart J., January 2, 2009; 30(2): 127 - 128. [Full Text] [PDF]